Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 33, which means every article in Journal of Stem Cell Research & Therapy has got 33 average citations.

Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Total published articles

22 58 59 65 23 13 36 34 49 63 101 62 44 26

Research, Review articles and Editorials

2 4 1 2 12 12 29 28 44 56 80 48 12 19

Research communications, Review communications, Editorial communications, Case reports and Commentary

20 54 58 63 11 1 7 6 5 7 21 14 32 6

Conference proceedings

0 40 12 37 0 0 145 138 95 63 154 72 54 0

Citations received as per Google Scholar, other indexing platforms and portals

522 678 761 838 697 626 613 599 538 478 262 142 31 69
Journal total citations count 6793
Journal impact factor 1.64
Journal 5 years impact factor 1.70
Journal cite score 11.56
Journal h-index 33
Important citations

Tsai MJ, Tsai SK, Huang MC, Liou DY, Huang SL, et al. (2015) Acidic FGF promotes neurite outgrowth of cortical neurons and improves neuroprotective effect in a cerebral ischemic rat model. Neuroscience 305: 238-247.

Wang J, Chen Y, Yang Y, Xiao X, Chen S, et al. (2016) Endothelial progenitor cells and neural progenitor cells synergistically protect cerebral endothelial cells from Hypoxia/reoxygenation-induced injury via activating the PI3K/Akt pathway. Molecular brain 9: 12.

Lu H, Liu X, Zhang N, Zhu X, Liang H, et al. (2016) Neuroprotective effects of brain-derived neurotrophic factor and noggin-modified bone mesenchymal stem cells in focal cerebral ischemia in rats. Journal of Stroke and Cerebrovascular Diseases 25: 410-418.

Costa R, Bergwerf I, Santermans E, De Vocht N, Praet J, et al. (2015) Distinct in vitro properties of embryonic and extraembryonic fibroblast-like cells are reflected in their in vivo behavior following grafting in the adult mouse brain. Cell transplantation 24: 223-233.

Filichia E, Shen H, Zhou X, Qi X, Jin K, et al. (2015) Forebrain neuronal specific ablation of p53 gene provides protection in a cortical ischemic stroke model. Neuroscience 295: 1-10.

Xu Y, Du S, Yu X, Han X, Hou J, et al. (2014) Human bone marrow mesenchymal stem cell transplantation attenuates axonal injury in stroke rats. Neural regeneration research 9: 2053.

dela Peña I, Borlongan CV (2015) Translating G-CSF as an adjunct therapy to stem cell transplantation for stroke. Translational stroke research 6: 421-429.

Achyut BR, Varma NR, Arbab AS (2014) Application of umbilical cord blood derived stem cells in diseases of the nervous system. Journal of stem cell research & therapy.

Zubcevic J, Santisteban MM, Pitts T, Baekey DM, Perez PD, et al. (2014) Functional Neural–Bone Marrow Pathways. Hypertension 63: e129-139.

Detante O, Jaillard A, Moisan A, Barbieux M, Favre IM, et al. (2014) Biotherapies in stroke. Revue neurologique 170: 779-798.

Tsai MJ, Tsai SK, Hu BR, Liou DY, Huang SL, et al. (2014) Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats. Journal of biomedical science 21: 5.

Huang Z, Song Y, Pang Z, Li M, Guliya Y, et al. (2016) Fibrin‐targeting delivery: a novel platform for cardiac regenerative medicine. Journal of Cellular and Molecular Medicine 20: 2410-2403.

Buzilă CA, Ifrim M, Micu AL (2016) Stem Cell Therapies as a Support for Cardiac Regeneration. InCoronary Graft Failure pp: 725-741.

Tang MY, Jin R, Zhang Y, Shi YM, Sun BS, et al. (2015) Advances in the research of autologous fibroblast injections for aging skin.

Chao TH, Chen IC, Tseng SY, Li YH (2014) Pluripotent stem cell therapy in ischemic cardiovascular disease. Acta Cardiologica Sinica 30: 365.

Malecki M, Putzer E, Sabo C, Foorohar A, Quach C, et al. (2014) Directed cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies. Molecular and cellular therapies 2: 13.

Malecki M (2014) ‘Above all, do no harm’: safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis. Stem cell research & therapy. 5: 73.

Malecki M, LaVanne C, Alhambra D, Dodivenaka C, Nagel S, et al. (2013) Safeguarding stem cell-based regenerative therapy against iatrogenic cancerogenesis: Transgenic expression of DNASE1, DNASE1L3, DNASE2, DFFB controlled by POLA1 promoter in proliferating and directed differentiation resisting human autologous pluripotent induced stem cells leads to their death. Journal of stem cell research & therapy.

Malecki M, Sabo C, Putzer E, Stampe C, Foorohar A, Quach C, et al. (2013) Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: novel strategy for cardiac regeneration. Molecular and cellular therapies 1: 4.

Zarogoulidis P, Darwiche K, Sakkas A, Yarmus L, Huang H, et al. (2013) Suicide gene therapy for cancer–current strategies. Journal of genetic syndrome & gene therapy.